Pfm Health Sciences, LP’s Penumbra Inc Position
Does Pfm Health Sciences, LP own Penumbra Inc (PEN)? Yes — 139.8K shares worth $46M (+4.19% of its 13F portfolio) as of Q1 2026, down from 145.2K shares the prior filed quarter.
Position Value
$46M
Q1 2026
Shares
139.8K
% of Portfolio
+4.19%
Quarters Held
30
currently held
Position History PEN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 139.8K | $46M | +4.19% |
| Q4 2025 | 145.2K | $45M | +4.50% |
| Q3 2025 | 195.1K | $49M | +3.80% |
| Q2 2025 | 166.3K | $43M | +3.63% |
| Q1 2025 | 166.3K | $44M | +3.23% |
| Q4 2024 | 166.3K | $39M | +2.45% |
| Q3 2024 | 166.3K | $32M | +1.83% |
| Q2 2024 | 185.1K | $33M | +1.65% |
| Q1 2024 | 155.8K | $35M | +1.63% |
| Q4 2023 | 155.8K | $39M | +2.35% |
| Q3 2023 | 192.4K | $47M | +2.19% |
| Q2 2023 | 360.0K | $124M | +4.81% |
| Q1 2023 | 360.0K | $100M | +4.43% |
| Q4 2022 | 360.0K | $80M | +2.87% |
| Q3 2022 | 360.0K | $68M | +2.47% |
| Q2 2022 | 182.8K | $23M | +0.87% |
| Q1 2022 | 166.7K | $37M | +1.38% |
| Q4 2021 | 177.1K | $51M | +1.73% |
| Q3 2021 | 177.1K | $47M | +1.39% |
| Q2 2021 | 133.8K | $37M | +1.15% |
| Q1 2021 | 74.4K | $20M | +0.61% |
| Q4 2020 | 199.7K | $35M | +1.23% |
| Q3 2020 | 239.4K | $47M | +2.15% |
| Q2 2020 | 111.3K | $20M | +1.03% |
| Q1 2020 | 118.2K | $19M | +1.57% |
| Q4 2019 | 418.8K | $69M | +3.28% |
| Q3 2019 | 1.03M | $138M | +4.09% |
| Q2 2019 | 771.8K | $123M | +2.35% |
| Q1 2019 | 727.1K | $107M | +2.36% |
| Q4 2018 | 902.9K | $110M | +2.93% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pfm Health Sciences, LP’s full portfolio or all institutional holders of PEN.